Open Access
- 11 November 2022
- journal article
- research article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 60 (5) , 554-559
Abstract
Objective – to investigate clinical and diagnostic significance of IL-31 and IL-33 determination in patients with rheumatoid arthritis (RA).Material and methods. 154 patients with a reliable diagnosis of RA were examined. Serum levels of IL-31 and IL-33 were studied using multiplex xMAP technology on Bio-PlexTM 200 System analyzer (BIO-RAD, USA). The upper limit of the norm in the study of 20 healthy donor sera was (M+3σ): IL-31 – 15.08 pg/ml, IL-33 – 3.40 pg/ml.Results. IL-31 (Me (25th; 75th percentile) – 13.75 (5.63; 308.52) and 6.10 (2.87; 8.62) pg/ml (p< 0.001), IL-33 – 18.86 (7.45; 65.95) and 0.52 (0.17; 0.78) pg/ml (p< 0.001) levels were observed in RA patients in comparison with the control group. An increase in IL-33 concentration (more than 3.40 pg/ml) was observed in 87.0% of patients, and IL-31 (more than 15.08 pg/ml) in 48.1% of patients with RA. An increase in IL-33 alone was observed in 42.2% (65 of 154 patients) with RA, while an isolated increase in IL-31 concentration was observed in only 2 (1.3%) patients. Simultaneous hyperproduction of IL-33 and IL-31 occurred in 69 (44.9%) patients. We revealed positive correlation of clinical and laboratory parameters of RA with cytokine concentration: SDAI correlated with IL-33 (r=0.36; p< 0.05); CRP – with IL-31 (r=0.49; p< ,05) and IL-33 (r=0.40; p<0.05)Conclusion. Concentrations of IL-31 and IL-33 are elevated in RA patients and correlate with the indices of inflammatory activity of the disease.Keywords
This publication has 42 references indexed in Scilit:
- Development of a Multi-Biomarker Disease Activity Test for Rheumatoid ArthritisPLOS ONE, 2013
- Increased IL-33 in Synovial Fluid and Paired Serum Is Associated with Disease Activity and Autoantibodies in Rheumatoid ArthritisJournal of Immunology Research, 2013
- Characterization of a multiplex, 12-biomarker test for rheumatoid arthritisJournal of Pharmaceutical and Biomedical Analysis, 2012
- Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritisCytokine, 2012
- IL-33 regulates TNF-α dependent effects in synovial fibroblastsInternational Journal of Molecular Medicine, 2012
- Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid ArthritisJournal of Korean Medical Science, 2011
- Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid ArthritisThe Journal of Rheumatology, 2010
- IL-33 Exacerbates Autoantibody-Induced ArthritisThe Journal of Immunology, 2010
- Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritisArthritis & Rheumatism, 2009
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008